Trial Site Detail

 

Drug:
Pazopanib (Votrient) + Topetecan (Hycamtin)
Trial:
Phase I, Combining Oral Topotecan With Oral Pazopanib
Conditions: Any type of Cancer
Trial Status:
Ongoing, but not recruiting

 

Universitair Medisch Centrum

Heidelberglaan 100     
Utrecht , 3584 CX
Netherlands

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Universitair Medisch Centrum Website:
http://www.umcutrecht.nl/zorg/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.